Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001959861-23-000001
Filing Date
2023-01-05
Accepted
2023-01-05 12:49:12
Documents
1
Effectiveness Date
2023-01-05
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 9646
  Complete submission text file 0001959861-23-000001.txt   10727
Mailing Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154
Business Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154 781-652-4500
Urica Therapeutics, Inc. (Filer) CIK: 0001959861 (see all company filings)

EIN.: 823474871 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-469777 | Film No.: 23510379